Cargando…

Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer

BACKGROUND: Breast cancer subtypes are known to have different metastatic recurrence sites. Distant metastases are often observed during the post-operative course in patients with human epidermal growth factor receptor 2 (HER2)-enriched breast cancer and triple-negative breast cancer, but are relati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takada, Koji, Kashiwagi, Shinichiro, Asano, Yuka, Goto, Wataru, Kouhashi, Rika, Yabumoto, Akimichi, Ishihara, Sae, Morisaki, Tamami, Shibutani, Masatsune, Tanaka, Hiroaki, Hirakawa, Kosei, Ohira, Masaichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164786/ https://www.ncbi.nlm.nih.gov/pubmed/34051785 http://dx.doi.org/10.1186/s12905-021-01373-7

Ejemplares similares

Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
por: Takada, Koji, et al.
Publicado: (2020)

The effect of smoking on biological change of recurrent breast cancer
por: Takada, Koji, et al.
Publicado: (2020)

Cowden Syndrome Diagnosed by Bilateral Breast Cancer with Lhermitte-Duclos Disease: A Case Report
por: Morisaki, Tamami, et al.
Publicado: (2020)

Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age
por: Takada, Koji, et al.
Publicado: (2022)

Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types
por: Morisaki, Tamami, et al.
Publicado: (2021)

Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy
por: Takada, Koji, et al.
Publicado: (2021)

Breast Angiosarcoma with a Preoperative Diagnosis of Late Recurrence of Breast Cancer: A Case Report
por: Kouhashi, Rika, et al.
Publicado: (2021)

Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer
por: Takada, Koji, et al.
Publicado: (2023)

Pathological Complete Response following Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma with Mammary Paget's Disease: A Case Report
por: Goto, Wataru, et al.
Publicado: (2021)

Predicting therapeutic efficacy of endocrine therapy for stage IV breast cancer by tumor-infiltrating lymphocytes
por: Asano, Yuka, et al.
Publicado: (2020)

Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment
por: Goto, Wataru, et al.
Publicado: (2020)

Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

Adenoid Cystic Carcinoma of the Breast: A Case Report
por: Kashiwagi, Shinichiro, et al.
Publicado: (2019)

Clinical verification of the relationship between serum lipid metabolism and immune activity in breast cancer patients treated with neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2023)

Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression
por: Asano, Yuka, et al.
Publicado: (2018)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2017)

Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment
por: Kashiwagi, Shinichiro, et al.
Publicado: (2018)

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2017)

Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
por: Ishihara, Sae, et al.
Publicado: (2019)

A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections
por: Iseki, Yasuhito, et al.
Publicado: (2018)

Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer
por: Wang, En, et al.
Publicado: (2021)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer
por: Takada, Koji, et al.
Publicado: (2019)

Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer
por: Takada, Koji, et al.
Publicado: (2019)

Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Continuous intraoperative neuromonitoring for thyroid cancer surgery: A prospective study
por: Onoda, Naoyoshi, et al.
Publicado: (2019)

Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
por: Asano, Yuka, et al.
Publicado: (2017)

Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2017)

Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer
por: Goto, Wataru, et al.
Publicado: (2018)

Verification of the methodology for evaluating tumor-infiltrating lymphocytes in colorectal cancer
por: Matsutani, Shinji, et al.
Publicado: (2018)

A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study
por: Shibutani, Masatsune, et al.
Publicado: (2018)

Severe pancytopenia caused by trifluridine/tipiracil in patients with metastatic colorectal cancer and an impaired renal function: A case report
por: Shibutani, Masatsune, et al.
Publicado: (2022)

Alveolar soft part sarcoma metastatic to the breast: a case report
por: Asano, Yuka, et al.
Publicado: (2019)

Significance of tumor‐infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
por: Matsutani, Shinji, et al.
Publicado: (2018)

Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment
por: Takada, Koji, et al.
Publicado: (2018)

Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
por: Goto, Wataru, et al.
Publicado: (2017)

Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report
por: Sera, Tomohiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pv2b2121fjltecblq08btei6s7